Archive

New weight loss medication may help lower blood pressure in adults with obesity

Written by | 5 Feb 2024

The new weight loss medication tirzepatide significantly lowered the systolic blood pressure (the top number in a blood pressure reading) for nearly 500 adults with obesity who took […]

Science’s 2023 Breakthrough of the Year: GLP-1 agonists show promise for obesity-associated health problems

Written by | 21 Dec 2023

Science has named the development of glucagon like peptide-1 (GLP-1) agonists and this year’s discovery that these drugs can blunt obesity-associated health problems as its 2023 Breakthrough of The […]

Tirzepatide enhances weight loss with sustained treatment but discontinuation leads to weight regain

Written by | 15 Dec 2023

The current class of anti-obesity drugs is proving remarkably effective at removing excess pounds. However, a phase 3 randomized clinical trial led by researchers at Weill Cornell Medicine […]

Obesity associated with more severe disease flares in early rheumatoid arthritis

Written by | 29 Nov 2023

Obesity is associated with worse flare symptoms and worse quality of life among patients with early rheumatoid arthritis, researchers reported on Nov. 12, 2023 at ACR Convergence 2023, […]

Globally, consumption of sugary drinks increased at least 16% since 1990

Written by | 6 Oct 2023

The decision to reach for a sugary beverage is heavily influenced by where you live, Friedman School of Nutrition Science and Policy researchers report in a new study published October 3 in […]

Obese women have worse menopause symptoms and get less relief from hormone therapy

Written by | 28 Sep 2023

Obesity has already been associated with a number of adverse health conditions and can interfere with a person’s quality of life. A new study suggests that, in addition […]

Obesity experts spotlight safety gap in clinical trials and drug labeling for people with obesity

Written by | 12 Sep 2023

A new opinion piece published in Health Affairs Forefront raises questions around current approaches to assess drug safety and effectiveness in people with obesity. The article sheds light on how […]

New study reveals the most common form of arthritis, osteoarthritis, affects 15% of the global population over the age of 30

Written by | 26 Aug 2023

A new study projects nearly 1 billion people will be living with osteoarthritis, the most common form of arthritis, by 2050. Currently, 15% of individuals aged 30 and […]

Pharmacy-led obesity management with GLP agonists

Written by | 21 Jun 2023

Deborah Evans is Superintendent Pharmacist and Clinic Director at Remedi Health, where she runs a weight management service, including the provision of semaglutide. In this series of short […]

Offering the best weight-loss service for patients

Written by | 20 Jun 2023

People seeking semaglutide for weight management from a pharmacy-led service need to feel assured that the service is ethical and legal and has the best interests of the […]

How to provide semaglutide for ethical weight-loss

Written by | 19 Jun 2023

Taking time to understand a patient’s weight loss goals and checking their medical history to ensure there are no underlying problems that may need onward referral are both […]

Semaglutide: what you need to know about online supply and effective use

Written by | 18 Jun 2023

Online supply of semaglutide makes the medicine more accessible but may not provide the best support or guidance to enable people to get the best out of the […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.